Copyright
©2013 Baishideng Publishing Group Co., Limited. All rights reserved.
World J Rheumatol. Nov 12, 2013; 3(3): 40-44
Published online Nov 12, 2013. doi: 10.5499/wjr.v3.i3.40
Published online Nov 12, 2013. doi: 10.5499/wjr.v3.i3.40
Lymphedema and rheumatological disorders
Sibel Eyigör, Physical Therapy and Rehabilitation Department, Faculty of Medicine, Ege University, 35100 Bornova, Izmir, Turkey
Author contributions: Eyigor S solely contributed to this paper.
Correspondence to: Sibel Eyigor, MD, Associate Professor, Physical Therapy and Rehabilitation Department, Faculty of Medicine, Ege University, Erzene Mh., 35100 Bornova, Izmir, Turkey. eyigor@hotmail.com
Telephone: +90-232-3903687 Fax: +90-232-3881953
Received: May 13, 2013
Revised: July 4, 2013
Accepted: July 17, 2013
Published online: November 12, 2013
Revised: July 4, 2013
Accepted: July 17, 2013
Published online: November 12, 2013
Core Tip
Core tip: Coexistence of inflammatory rheumatological diseases and lymphedema is an under-recognized subject. Drawing clinicians’ attention to this issue is important for improving patients’ quality of life. In patients with inflammatory rheumatological disease and lymphedema, although the complex decongestive therapy method is the primary approach, tumor necrosis factor-α inhibitors mentioned in the literature, whose efficacy requires explanation, may also be tried.